MAPK8IP1P2 and thyroid cancer: In the current study, we found that MAPK8IP1P2 was downregulated in thyroid cancer tissues, and particularly in thyroid cancer tissues with lymphatic metastasis, which was correlated with poor progression-free survival in thyroid cancer patients.